As a national Life Sciences service, we share innovators’ goals to transform discovery and develop medicines so better treatments get to more patients, faster. By supporting your drug discovery, we accelerate the development of your science and where there are areas of unmet patient need, we stimulate innovation.
Drug discovery is high risk, and it can be challenging for innovators to navigate the sector and unlock the funding or resources they need.
We reduce this risk and create momentum by connecting the most promising innovators to cutting-edge capabilities, technology, expertise, insights, and sector-leading partnerships.
That's why, we have supported over 300 innovators, helping them raise over £1bn of R&D investment and supporting them to take five new drugs to clinical trials, creating a roadmap for commercial success.
